SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. Nina Kim, Carla V. Rodriguez, Stephen Van Rompaey, Joseph J. Eron, Chloe L. Thio, Heidi M. Crane, Edgar T. Overton, Michael S. Saag, Jeffrey Martin, Elvin Geng, Michael Mugavero, Benigno Rodriguez, W. Christopher Mathews, Stephen Boswell, Richard Moore, Mari M. Kitahata, Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, 66, 1, 96

    CrossRef

  2. 2
    Lindsay A. Petty, Jennifer L. Steinbeck, Kenneth Pursell, Donald M. Jensen, Human Immunodeficiency Virus and Coinfection with Hepatitis B and C, Infectious Disease Clinics of North America, 2014, 28, 3, 477

    CrossRef

  3. 3
    J. S. Hafkin, M. K. Osborn, A. R. Localio, V. K. Amorosa, J. R. Kostman, J. J. Stern, P. Torre, K. Mounzer, I. Frank, R. Gross, K.-M. Chang, V. Lo Re, Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy, Journal of Viral Hepatitis, 2014, 21, 4
  4. 4
    Minhee Kang, Kimberly Hollabaugh, Vinh Pham, Susan L. Koletar, Kunling Wu, Marlene Smurzynski, Judith A. Aberg, Virologic and Serologic Outcomes of Mono vs. Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, 1

    CrossRef

  5. 5
    Raph L. Hamers, Hans L. Zaaijer, Carole L. Wallis, Margaret Siwale, Prudence Ive, Mariette E. Botes, Kim C. E. Sigaloff, Andy I. M. Hoepelman, Wendy S. Stevens, Tobias F. Rinke de Wit, HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013, 64, 2, 174

    CrossRef

  6. 6
    G. V. Matthews, E. C. Seaberg, A. Avihingsanon, S. Bowden, G. J. Dore, S. R. Lewin, J. Sasadeusz, P. A. Revill, M. Littlejohn, J. F. Hoy, R. Finlayson, K. Ruxrungtham, M. Saulynas, S. Locarnini, C. L. Thio, Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus, Clinical Infectious Diseases, 2013, 56, 9, e87

    CrossRef

  7. You have free access to this content7
    Geoffrey Dusheiko, Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues, Liver International, 2013, 33,
  8. 8
    L. Kosi, T. Reiberger, B. A. Payer, K. Grabmeier-Pfistershammer, R. Strassl, A. Rieger, M. Peck-Radosavljevic, Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients, Journal of Viral Hepatitis, 2012, 19, 11
  9. 9
    R. Zoutendijk, H. L. Zaaijer, T. E. M. S. de Vries-Sluijs, J. G. P. Reijnders, J. W. Mulder, F. P. Kroon, C. Richter, A. A. van der Eijk, M. J. Sonneveld, B. E. Hansen, R. A. de Man, M. E. van der Ende, H. L. A. Janssen, Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV, Journal of Infectious Diseases, 2012, 206, 6, 974

    CrossRef

  10. 10
    Olivier Lada, Anne Gervais, Michel Branger, Gilles Peytavin, Benedicte Roquebert, Gilles Collin, Gil Fraqueiro, Rami Moucari, Gwen Hamet, Michelle Martinot-Peignoux, Sophie Matheron, Patrick Marcellin, Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G, Liver International, 2012, 32, 1
  11. 11
    Runu Chakravarty, Role of molecular diagnostics in the management of viral hepatitis B, Expert Opinion on Medical Diagnostics, 2012, 6, 5, 395

    CrossRef

  12. 12
    S. Pol, F. Bailly, Foie et virus de l'immunodéficience humaine, EMC - Hépatologie, 2011, 6, 2, 1

    CrossRef

  13. 13
    Gail V. Matthews, Prince Manzini, Zonghui Hu, Paul Khabo, Patrick Maja, Gugu Matchaba, Phumele Sangweni, Julie Metcalf, Nicholaas Pool, Susan Orsega, Sean Emery, Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa, AIDS, 2011, 25, 14, 1727

    CrossRef

  14. 14
    Maria Mendes-Correa, João RR Pinho, Michele S Gomes-Gouvea, Adriana C da Silva, Cristina F Guastini, Luiz G Martins, Andréa G Leite, Mariliza H Silva, Reinaldo J Gianini, David E Uip, Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil, BMC Infectious Diseases, 2011, 11, 1, 247

    CrossRef

  15. 15
    Hitendra Garg, Shiv Kumar Sarin, Manoj Kumar, Vishal Garg, Barjesh Chander Sharma, Ashish Kumar, Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure , Hepatology, 2011, 53, 3
  16. 16
    Derek Yu, Jenny Heathcote, Tenofovir in the treatment of chronic hepatitis B, Therapy, 2011, 8, 5, 527

    CrossRef

  17. 17
    Irene N Rapti, Stephanos J Hadziyannis, Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323

    CrossRef

  18. 18
    Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts, Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections, Viruses, 2010, 2, 6, 1279

    CrossRef

  19. You have free access to this content19
    G Brook, J Main, M Nelson, S Bhagani, E Wilkins, C Leen, M Fisher, Y Gilleece, R Gilson, A Freedman, R Kulasegaram, K Agarwal, C Sabin, C Deacon-Adams, British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010, HIV Medicine, 2010, 11, 1
  20. 20
    Gregory J Dore, Vicente Soriano, Jürgen Rockstroh, Bernd Kupfer, Ellen Tedaldi, Lars Peters, Jacqueline Neuhaus, Massimo Puoti, Marina B Klein, Amanda Mocroft, Bonaventura Clotet, Jens D Lundgren, Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption, AIDS, 2010, 24, 6, 857

    CrossRef

  21. 21
    Theodora E.M.S. de Vries–Sluijs, Jurriën G.P. Reijnders, Bettina E. Hansen, Hans L. Zaaijer, Jan M. Prins, Suzan D. Pas, Martin Schutten, Andy I.M. Hoepelman, Clemens Richter, Jan W. Mulder, Rob A. de Man, Harry L.A. Janssen, Marchina E. van der Ende, Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus, Gastroenterology, 2010, 139, 6, 1934

    CrossRef

  22. 22
    L. Martin-Carbonero, V. Soriano, New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients, Journal of Antimicrobial Chemotherapy, 2010, 65, 3, 379

    CrossRef

  23. 23
    T. Asselah, O. Lada, P. Marcellin, Résultats des essais thérapeutiques dans l’hépatite chronique B, Antibiotiques, 2010, 12, 1, 42

    CrossRef

  24. 24
    R. Pais, Y. Benhamou, Traitements à long terme de l’hépatite chronique B chez le patient co-infecté par le VIH, Gastroentérologie Clinique et Biologique, 2010, 34, S136

    CrossRef

  25. 25
    Jennifer A. Johnson, Paul E. Sax, Antiretroviral therapy for treatment-naïve patients: A review of recent literature and the updated guidelines, Current Infectious Disease Reports, 2009, 11, 4, 311

    CrossRef

  26. 26
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B, Journal of Hepatology, 2009, 50, 2, 227

    CrossRef

  27. 27
    Dennis J. Cada, Terri L. Levien, Danial E. Baker, Formulary Drug Reviews - Tenofovir Disoproxil Fumarate Tablets, Hospital Pharmacy, 2009, 44, 2, 165

    CrossRef

  28. 28
    Melissa Osborn, Hepatitis B in HIV: Available treatment options and approach to therapy, Current Infectious Disease Reports, 2009, 11, 5, 407

    CrossRef

  29. 29
    Marie-Louise Vachon, Douglas T. Dieterich, HIV and coinfected patients, Current Hepatitis Reports, 2009, 8, 3, 103

    CrossRef

  30. 30
    Si Nafa Si Ahmed, Fabien Zoulim, Pathobiology of HBV mutants and clinical impact for treatment monitoring, Expert Review of Anti-infective Therapy, 2009, 7, 3, 309

    CrossRef

  31. 31
    Man-Fung Yuen, James Fung, Danny Ka-Ho Wong, Ching-Lung Lai, Prevention and management of drug resistance for antihepatitis B treatment, The Lancet Infectious Diseases, 2009, 9, 4, 256

    CrossRef

  32. 32
    European Association for the Stud, Recommandations de pratiques cliniques de l’EASL. Prise en charge de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2009, 33, 6-7, 539

    CrossRef

  33. 33
    L. K. K. Tan, Y. Gilleece, S. Mandalia, A. Murungi, D. Grover, M. Fisher, M. Atkins, M. Nelson, Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir, Journal of Viral Hepatitis, 2009, 16, 7
  34. 34
    Robert J. Fontana, Side effects of long-term oral antiviral therapy for hepatitis B, Hepatology, 2009, 49, S5
  35. 35
    Janet C. Yang, Steven-Huy B. Han, Society guidelines, US treatment algorithm, and NIH consensus: Similarities and differences in management of hepatitis B, Current Hepatitis Reports, 2009, 8, 4, 161

    CrossRef

  36. 36
    Alice M. Jenh, Chloe L. Thio, Paul A. Pham, Tenofovir for the Treatment of Hepatitis B Virus, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009, 29, 10
  37. 37
    Sharon R. Lewin, Ruy M. Ribeiro, Anchalee Avihingsanon, Scott Bowden, Gail Matthews, Pip Marks, Stephen A. Locarnini, Kiat Ruxrungtham, Alan S. Perelson, Gregory J. Dore, Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy, Hepatology, 2009, 49, 4
  38. 38
    Gail V. Matthews, Anchalee Avihingsanon, Sharon R. Lewin, Janaki Amin, Rungsun Rerknimitr, Panusit Petcharapirat, Pip Marks, Joe Sasadeusz, David A. Cooper, Scott Bowden, Stephen Locarnini, Kiat Ruxrungtham, Gregory J. Dore, A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand, Hepatology, 2008, 48, 4
  39. 39
    Emmet B. Keeffe, Douglas T. Dieterich, Steven-Huy B. Han, Ira M. Jacobson, Paul Martin, Eugene R. Schiff, Hillel Tobias, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update, Clinical Gastroenterology and Hepatology, 2008, 6, 12, 1315

    CrossRef

  40. 40
    María Buti, Análogos de nucleósidos y nucleótidos en el tratamiento de la hepatitis crónica por el virus B, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 32

    CrossRef

  41. 41
    Geoffrey Férir, Suzanne Kaptein, Johan Neyts, Erik De Clercq, Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future, Reviews in Medical Virology, 2008, 18, 1
  42. 42
    Vincent Soriano, Massimo Puoti, Marion Peters, Yves Benhamou, Mark Sulkowski, Fabien Zoulim, Stefan Mauss, Juergen Rockstroh, Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel, AIDS, 2008, 22, 12, 1399

    CrossRef

  43. 43
    Ira M. Jacobson, Combination therapy for chronic hepatitis B: Ready for prime time?, Journal of Hepatology, 2008, 48, 5, 687

    CrossRef

  44. 44
    Mari Inada, Osamu Yokosuka, Current antiviral therapies for chronic hepatitis B, Hepatology Research, 2008, 38, 6
  45. 45
    Rong-Nan Chien, Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B, Hepatology International, 2008, 2, 3, 296

    CrossRef

  46. 46
    Aimi Kanada, Tetsuo Takehara, Kazuyoshi Ohkawa, Michio Kato, Tomohide Tatsumi, Takuya Miyagi, Ryotaro Sakamori, Shinjiro Yamaguchi, Akio Uemura, Keisuke Kohga, Akira Sasakawa, Hayato Hikita, Kiyomi Kawamura, Tatsuya Kanto, Naoki Hiramatsu, Norio Hayashi, Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection, Hepatology Research, 2008, 38, 6
  47. 47
    Mário Guimarães Pessôa, Brian Gazzard, Anna K Huang, Carlos E Brandão-Mello, Isabel Cassetti, Maria Cassia Mendes-Corrêa, Vicente Soriano, Phillip Phiri, Andrea Hall, Helena Brett-Smith, Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy, AIDS, 2008, 22, 14, 1779

    CrossRef

  48. 48
    Stephen Barclay, Stanislas Pol, David Mutimer, Yves Benhamou, Peter R. Mills, Peter C. Hayes, Sheila Cameron, William Carman, Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243–254], Journal of Clinical Virology, 2008, 42, 1, 104

    CrossRef

  49. 49
    Pablo Barreiro, Luz Martín-Carbonero, Javier García-Samaniego, Hepatitis B en pacientes con infección por el virus de la inmunodeficiencia humana, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 71

    CrossRef

  50. 50
    Michael Nassal, Hepatitis B viruses: Reverse transcription a different way, Virus Research, 2008, 134, 1-2, 235

    CrossRef

  51. 51
    Reto Nüesch, Jintanat Ananworanich, Preeyaporn Srasuebkul, Ploenchan Chetchotisakd, Wisit Prasithsirikul, Wirat Klinbuayam, Apicha Mahanontharit, Thidarat Jupimai, Kiat Ruxrungtham, Bernard Hirschel, Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection, AIDS, 2008, 22, 1, 152

    CrossRef

  52. 52
    J.-P. Zarski, V. Leroy, Le patient atteint d’hépatite chronique B non contrôlé, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S7

    CrossRef

  53. 53
    Vincent Soriano, Eugenia Vispo, Marcelle Bottecchia, Julie Sheldon, Paula Tuma, Javier Garcia-Samaniego, Pablo Barreiro, Management of hepatitis B virus co-infection on and off antiretroviral therapy, Current HIV/AIDS Reports, 2008, 5, 2, 86

    CrossRef

  54. 54
    J.G.P. Reijnders, H.L.A. Janssen, Potency of tenofovir in chronic hepatitis B: Mono or combination therapy?, Journal of Hepatology, 2008, 48, 3, 383

    CrossRef

  55. 55
    Florian van Bömmel, Thomas Berg, Role of tenofovir in the treatment of chronic HBV infection, Future Virology, 2008, 3, 3, 207

    CrossRef

  56. 56
    S. Gutierrez, S. Guillemi, N. Jahnke, V. Montessori, P. R. Harrigan, J. S. G. Montaner, Tenofovir-Based Rescue Therapy for Advanced Liver Disease in 6 Patients Coinfected with HIV and Hepatitis B Virus and Receiving Lamivudine, Clinical Infectious Diseases, 2008, 46, 3, e28

    CrossRef

  57. 57
    Marcelle Bottecchia, Javier Garcia-Samaniego, Vincent Soriano, The implications of antiviral drugs with activity against hepatitis B virus and HIV, Current Opinion in Internal Medicine, 2008, 7, 1, 57

    CrossRef

  58. 58
    Stephen Barclay, Stanislas Pol, David Mutimer, Yves Benhamou, Peter R. Mills, Peter C. Hayes, Sheila Cameron, William Cameron, The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting, Journal of Clinical Virology, 2008, 41, 4, 243

    CrossRef

  59. 59
    T. Asselah, O. Lada, N. Boyer, M. Martinot, P. Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 749

    CrossRef

  60. 60
    J. Massard, Y. Benhamou, Traitement de l’hépatite chronique B chez les patients co-infectés par le VIH, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S20

    CrossRef

  61. 61
    Stefan Mauss, Heiner Wedemeyer, Treatment of chronic hepatitis B and the implications of viral resistance to therapy, Expert Review of Anti-infective Therapy, 2008, 6, 2, 191

    CrossRef

  62. 62
    G. Carosi, M. Rizzetto, Treatment of chronic hepatitis B: Recommendations from an Italian workshop, Digestive and Liver Disease, 2008, 40, 8, 603

    CrossRef

  63. 63
    Bijal Surti, Amanda C. Chi, Sammy Saab, Update on management of hepatitis B before and after liver transplantation, Current Hepatitis Reports, 2008, 7, 1, 25

    CrossRef

  64. 64
    E. De Clercq, Acyclic nucleoside phosphonates: Past, present and future, Biochemical Pharmacology, 2007, 73, 7, 911

    CrossRef

  65. 65
    Claire Fournier, Fabien Zoulim, Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance, Clinics in Liver Disease, 2007, 11, 4, 869

    CrossRef

  66. 66
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  67. 67
    M. Bourlière, H. Fontaine, Y. Yazdanpanah, L. Piroth, Y. Benhamou, Co-infection avec les hépatites virales, Journal Africain d’Hépato-Gastroentérologie, 2007, 1, 1, 38

    CrossRef

  68. 68
    Oliver Schildgen, Florian van Bömmel, Jürgen K Rockstroh, Current and future therapies for chronic HBV-infections, Reviews in Medical Microbiology, 2007, 18, 4, 79

    CrossRef

  69. 69
    Lionel Piroth, Damien S??ne, Stanislas Pol, Isabelle Goderel, Karine Lacombe, Benoit Martha, David Rey, V??ronique Loustau-Ratti, Jean-Fran??ois Bergmann, Gilles Pialoux, Anne Gervais, Caroline Lascoux-Combe, Fabrice Carrat, Patrice Cacoub, Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY), AIDS, 2007, 21, 10, 1323

    CrossRef

  70. 70
    Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal, Hepatitis B and End-Stage Liver Disease, Clinics in Liver Disease, 2007, 11, 4, 893

    CrossRef

  71. 71
    Yves Benhamou, Hepatitis B in the HIV-Coinfected Patient, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007, 45, Supplement 2, S57

    CrossRef

  72. 72
    Pascale Trimoulet, Mathieu Boutonnet, Maria Winnock, Muriel Faure, Marc-Arthur Loko, Victor De Lédinghen, Pierre-Henri Bernard, Laurent Castéra, Juliette Foucher, Michel Dupon, Jean-Marie Ragnaud, Marie-Édith Lafon, Patrice Couzigou, François Dabis, Hervé Fleury, Didier Neau, Hepatitis B virus genotypes : a retrospective survey in Southwestern France, 1999-2004, Gastroentérologie Clinique et Biologique, 2007, 31, 12, 1088

    CrossRef

  73. 73
    Kwan Sik Lee, Dong Joon Kim, Management of Chronic Hepatitis B, The Korean Journal of Hepatology, 2007, 13, 4, 447

    CrossRef

  74. 74
    Walid S. Ayoub, Emmet B. Keeffe, Management of hepatitis B in patients with HBeAg-negative disease, Current Hepatitis Reports, 2007, 6, 3, 91

    CrossRef

  75. 75
    Emmet B. Keeffe, Patrick Marcellin, New and Emerging Treatment of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2007, 5, 3, 285

    CrossRef

  76. 76
    Albert D. Min, Jules L. Dienstag, Oral Antivirals for Chronic Hepatitis B, Clinics in Liver Disease, 2007, 11, 4, 851

    CrossRef

  77. 77
    Patrice Cacoub, Lionel Piroth, Prise en charge des malades coinfectés VIH-VHC et VIH-VHB, Gastroentérologie Clinique et Biologique, 2007, 31, 10, 887

    CrossRef

  78. 78
    David J Quan, Marion G Peters, Tenofovir disoproxil fumarate for the treatment of hepatitis B virus infection: pharmacokinetics and clinical efficacy, Therapy, 2007, 4, 2, 141

    CrossRef

  79. 79
    Gail Matthews, The management of HIV and hepatitis B coinfection, Current Opinion in Infectious Diseases, 2007, 20, 1, 16

    CrossRef

  80. 80
    Srinivas Cheruvu, Kristen Marks, Andrew H. Talal, Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus Coinfection, Clinics in Liver Disease, 2007, 11, 4, 917

    CrossRef

  81. 81
    Erik De Clercq, 2007,

    CrossRef

  82. 82
    Guenther Schmutz, Mark Nelson, Thomas Lutz, Julie Sheldon, Raffaele Bruno, Florian von Boemmel, Christian Hoffmann, Juergen Rockstroh, Albrecht Stoehr, Eva Wolf, Vincent Soriano, Florian Berger, Thomas Berg, Amina Carlebach, Carolynne Schwarze-Zander, Dirk Schürmann, Hans Jaeger, Stefan Mauss, Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection, AIDS, 2006, 20, 15, 1951

    CrossRef

  83. 83
    Erik De Clercq, From adefovir to Atripla™ via tenofovir, Viread™ and Truvada™, Future Virology, 2006, 1, 6, 709

    CrossRef

  84. 84
    Jenny O. Smith, Richard K. Sterling, Hiv coinfection with hepatitis C and hepatitis B, Current Infectious Disease Reports, 2006, 8, 5, 409

    CrossRef

  85. 85
    Tomas Cihlar, Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond, Current Opinion in HIV and AIDS, 2006, 1, 5, 373

    CrossRef

  86. 86
    J. García-Samaniego, Nuevos fármacos para el tratamiento de la hepatitis crónica por virus B, Gastroenterología y Hepatología, 2006, 29, 54

    CrossRef

  87. 87
    Marc Bourlière, Perspectives et stratégies futures dans la prise en charge de la résistance aux analogues antiviraux dans le traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2006, 30, 10, 34

    CrossRef

  88. 88
    Marion G. Peters, Janet Andersen, Patrick Lynch, Tun Liu, Beverly Alston-Smith, Carol L. Brosgart, Jeffrey M. Jacobson, Victoria A. Johnson, Richard B. Pollard, James F. Rooney, Kenneth E. Sherman, Susan Swindells, Bruce Polsky, Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127, Hepatology, 2006, 44, 5
  89. 89
    Stephen N. Wong, Anna S.F. Lok, Tenofovir disoproxil fumarate: Role in hepatitis B treatment, Hepatology, 2006, 44, 2
  90. 90
    Yves Benhamou, Traitement de l’hépatite chronique B résistant à la lamivudine chez les malades co-infectés par le VIH, Gastroentérologie Clinique et Biologique, 2006, 30, 10, 22

    CrossRef

  91. 91
    Armando Sánchez-Quijano, Eduardo Lissen, Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 7, 453

    CrossRef

  92. 92
    Marie-Louise Vachon, Ponni Perumalswami, Douglas T. Dieterich, Hepatobiliary Manifestations of Human Immunodeficiency Virus,